GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ABCB · Jun 30, 2025

Ameris Bancorp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000351569-25-000022Bank
Sequential deposit growth20thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

0.09% · CORE · VALID

Net-income growth55thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

20.98% · CORE · VALID

Interest-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

0.09% · CORE · VALID

Cash and equivalents20thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.2B · CORE · VALID

Sequential loan growth50thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.66% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History52 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
0.87%
Current
0.09%
Delta
-0.78%
Earnings Growth Increased
Previous
18.33%
Current
20.98%
Delta
2.65%
Interest Income Growth Decreased
Previous
1.31%
Current
0.09%
Delta
-1.22%
Liquidity Decreased
Previous
$1.3B
Current
$1.2B
Delta
-$122.1M
Loan Growth Increased
Previous
-0.20%
Current
1.66%
Delta
1.86%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.